Actively Recruiting
Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes
Led by Tianjin Medical University General Hospital · Updated on 2024-12-24
2000
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to establish a registry, screening, and individualized management platform for patients with monogenic diabetes mellitus(MDM) using internet-based and mobile application software. The main questions it aims to answer are: * What are the genetic mutations causing MDM in China (genetic landscape)? * How effective and safe is the individualized, molecular-diagnosis-based management platform for MDM in improving patient outcomes? Participants will: * Register in the MDM platform via mobile app or internet-based software * Undergo genetic screening for MDM diagnosis * Participate in follow-up visits for individualized management and monitoring of blood glucose control and outcomes
CONDITIONS
Official Title
Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diabetes patients who developed before 25 years old; Or diagnosed with diabetes before age 35 with two or more immediate relatives diagnosed before 45
- Body mass index (BMI) at diagnosis less than 28 kg/m2
- Negative for anti glutamic acid decarboxylase antibody (GAD Ab), anti islet cell antibody (ICA Ab), and anti insulin autoantibody (IAA Ab)
You will not qualify if you...
- Secondary diabetes caused by other endocrine diseases such as hyperthyroidism, hypothyroidism, acromegaly, Cushing's syndrome, or autoimmune multiple endocrine diseases
- Use of systemic corticosteroids, immunosuppressants, or similar drugs within the past 6 months
- Presence of malignant tumors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tianjin Medical University General Hospital
Tianjin, China, 300052
Actively Recruiting
Research Team
M
Ming Liu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here